Cargando…
减低强度预处理并更换供者二次异基因造血干细胞移植治疗移植后复发恶性血液病44例临床研究
OBJECTIVE: The purpose of this study was to assess the safety and efficacy of a second allogeneic hematopoietic stem cell transplantation(allo-HSCT)with reduced-intensity conditioning(RIC)in patients with hematological malignancies who had relapsed after the first allo-HSCT. METHODS: Between April 2...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450545/ https://www.ncbi.nlm.nih.gov/pubmed/37550201 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.06.004 |
Ejemplares similares
-
二次异基因造血干细胞移植治疗70例移植后复发恶性血液病患者的疗效及安全性
Publicado: (2023) -
减低强度预处理异基因造血干细胞移植治疗10例骨髓纤维化患者的临床观察
Publicado: (2018) -
增加强度预处理单倍体造血干细胞移植治疗10例HLA供者特异性抗体(DSA)强阳性血液病患者临床观察
Publicado: (2023) -
供者来源CD19-CAR-T细胞在异基因造血干细胞移植后复发B细胞恶性肿瘤中的应用
Publicado: (2016) -
我如何选择异基因造血干细胞移植供者
Publicado: (2016)